Cargando…

Total Thyroidectomy Versus Lobectomy for Thyroid Cancer: Single-Center Data and Literature Review

BACKGROUND: Controversies remain about the ideal risk-based surgical approach for differentiated thyroid cancer (DTC). METHODS: At a single tertiary care institution, 370 consecutive patients with low- or intermediate-risk DTC were submitted to either lobectomy (LT) or total thyroidectomy (TT) and w...

Descripción completa

Detalles Bibliográficos
Autores principales: Colombo, Carla, De Leo, Simone, Di Stefano, Marta, Trevisan, Matteo, Moneta, Claudia, Vicentini, Leonardo, Fugazzola, Laura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253713/
https://www.ncbi.nlm.nih.gov/pubmed/33566240
http://dx.doi.org/10.1245/s10434-020-09481-8
_version_ 1783717572157374464
author Colombo, Carla
De Leo, Simone
Di Stefano, Marta
Trevisan, Matteo
Moneta, Claudia
Vicentini, Leonardo
Fugazzola, Laura
author_facet Colombo, Carla
De Leo, Simone
Di Stefano, Marta
Trevisan, Matteo
Moneta, Claudia
Vicentini, Leonardo
Fugazzola, Laura
author_sort Colombo, Carla
collection PubMed
description BACKGROUND: Controversies remain about the ideal risk-based surgical approach for differentiated thyroid cancer (DTC). METHODS: At a single tertiary care institution, 370 consecutive patients with low- or intermediate-risk DTC were submitted to either lobectomy (LT) or total thyroidectomy (TT) and were followed up. RESULTS: Event-free survival by Kaplan–Meier curves was significantly higher after TT than after LT for the patients with either low-risk (P = 0.004) or intermediate-risk (P = 0.032) tumors. At the last follow-up visit, the prevalence of event-free patients was higher in the TT group than in the LT low-risk group (95% and 87.5%, respectively; P = 0.067) or intermediate-risk group (89% and 50%; P = 0.008). No differences in persistence prevalence were found among microcarcinomas treated by LT or TT (low risk, P = 0.938 vs. intermediate-risk, P = 0.553). Nevertheless, 15% of the low-risk and 50% of the intermediate-risk microcarcinomas treated by LT were submitted to additional treatments. On the other hand, macrocarcinomas were significantly more persistent if treated with LT than with TT (low-risk, P = 0.036 vs. intermediate-risk, P = 0.004). Permanent hypoparathyroidism was more frequent after TT (P = 0.01). After LT, thyroglobulin (Tg)/thyroid-stimulating hormone (TSH) had shown decreasing trend in 68% of the event-free patients and an increasing trend in the persistent cases. CONCLUSIONS: Lobectomy can be proposed for low-risk microcarcinomas, although in a minority of cases, additional treatments are needed, and a longer follow-up period usually is required to confirm an event-free outcome compared with that for patients treated with TT. On the other hand, to achieve an excellent response, TT should be favored for intermediate-risk micro- and macro-DTCs despite the higher frequency of postsurgical complications. SUPPLEMENTARY INFORMATION: The online version of this article (10.1245/s10434-020-09481-8) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-8253713
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-82537132021-07-20 Total Thyroidectomy Versus Lobectomy for Thyroid Cancer: Single-Center Data and Literature Review Colombo, Carla De Leo, Simone Di Stefano, Marta Trevisan, Matteo Moneta, Claudia Vicentini, Leonardo Fugazzola, Laura Ann Surg Oncol Endocrine Tumors BACKGROUND: Controversies remain about the ideal risk-based surgical approach for differentiated thyroid cancer (DTC). METHODS: At a single tertiary care institution, 370 consecutive patients with low- or intermediate-risk DTC were submitted to either lobectomy (LT) or total thyroidectomy (TT) and were followed up. RESULTS: Event-free survival by Kaplan–Meier curves was significantly higher after TT than after LT for the patients with either low-risk (P = 0.004) or intermediate-risk (P = 0.032) tumors. At the last follow-up visit, the prevalence of event-free patients was higher in the TT group than in the LT low-risk group (95% and 87.5%, respectively; P = 0.067) or intermediate-risk group (89% and 50%; P = 0.008). No differences in persistence prevalence were found among microcarcinomas treated by LT or TT (low risk, P = 0.938 vs. intermediate-risk, P = 0.553). Nevertheless, 15% of the low-risk and 50% of the intermediate-risk microcarcinomas treated by LT were submitted to additional treatments. On the other hand, macrocarcinomas were significantly more persistent if treated with LT than with TT (low-risk, P = 0.036 vs. intermediate-risk, P = 0.004). Permanent hypoparathyroidism was more frequent after TT (P = 0.01). After LT, thyroglobulin (Tg)/thyroid-stimulating hormone (TSH) had shown decreasing trend in 68% of the event-free patients and an increasing trend in the persistent cases. CONCLUSIONS: Lobectomy can be proposed for low-risk microcarcinomas, although in a minority of cases, additional treatments are needed, and a longer follow-up period usually is required to confirm an event-free outcome compared with that for patients treated with TT. On the other hand, to achieve an excellent response, TT should be favored for intermediate-risk micro- and macro-DTCs despite the higher frequency of postsurgical complications. SUPPLEMENTARY INFORMATION: The online version of this article (10.1245/s10434-020-09481-8) contains supplementary material, which is available to authorized users. Springer International Publishing 2021-02-10 2021 /pmc/articles/PMC8253713/ /pubmed/33566240 http://dx.doi.org/10.1245/s10434-020-09481-8 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Endocrine Tumors
Colombo, Carla
De Leo, Simone
Di Stefano, Marta
Trevisan, Matteo
Moneta, Claudia
Vicentini, Leonardo
Fugazzola, Laura
Total Thyroidectomy Versus Lobectomy for Thyroid Cancer: Single-Center Data and Literature Review
title Total Thyroidectomy Versus Lobectomy for Thyroid Cancer: Single-Center Data and Literature Review
title_full Total Thyroidectomy Versus Lobectomy for Thyroid Cancer: Single-Center Data and Literature Review
title_fullStr Total Thyroidectomy Versus Lobectomy for Thyroid Cancer: Single-Center Data and Literature Review
title_full_unstemmed Total Thyroidectomy Versus Lobectomy for Thyroid Cancer: Single-Center Data and Literature Review
title_short Total Thyroidectomy Versus Lobectomy for Thyroid Cancer: Single-Center Data and Literature Review
title_sort total thyroidectomy versus lobectomy for thyroid cancer: single-center data and literature review
topic Endocrine Tumors
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253713/
https://www.ncbi.nlm.nih.gov/pubmed/33566240
http://dx.doi.org/10.1245/s10434-020-09481-8
work_keys_str_mv AT colombocarla totalthyroidectomyversuslobectomyforthyroidcancersinglecenterdataandliteraturereview
AT deleosimone totalthyroidectomyversuslobectomyforthyroidcancersinglecenterdataandliteraturereview
AT distefanomarta totalthyroidectomyversuslobectomyforthyroidcancersinglecenterdataandliteraturereview
AT trevisanmatteo totalthyroidectomyversuslobectomyforthyroidcancersinglecenterdataandliteraturereview
AT monetaclaudia totalthyroidectomyversuslobectomyforthyroidcancersinglecenterdataandliteraturereview
AT vicentinileonardo totalthyroidectomyversuslobectomyforthyroidcancersinglecenterdataandliteraturereview
AT fugazzolalaura totalthyroidectomyversuslobectomyforthyroidcancersinglecenterdataandliteraturereview